Merck, known as MSD outside the United States and Canada, announced new leadership for its Human Health business.

Arpa Garay will lead Human Health Global Marketing, Jannie Oosthuizen will lead Human Health U.S., and Merck is recruiting externally to fill the Human Health International role.

In the interim, Deepak Khanna will lead Human Health International.

These three positions will sit on the Executive Team and report directly to Robert M. Davis, CEO and President, Merck. These appointments will be effective Feb. 28, 2022.

“Our human health business has a remarkable track record of operational excellence, strategic execution and strong results, and our deep bench of global talent has made that possible,” Davis said. “These appointments will enable us to build on this momentum, develop our internal talent and expand our high performing senior leadership team. I am confident that this structure will help to further focus and optimize our business operations and ensure we are well positioned to achieve our business goals and continue to save and improve lives.”